{"status":"ok","message-type":"work-list","message-version":"1.0.0","message":{"facets":{},"total-results":26610,"items":[{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:06:44Z","timestamp":1648778804390},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1983,1,1]],"date-time":"1983-01-01T00:00:00Z","timestamp":410227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"},{"start":{"date-parts":[[1983,1,1]],"date-time":"1983-01-01T00:00:00Z","timestamp":410227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Urol"],"published-print":{"date-parts":[[1983]]},"DOI":"10.1159\/000474116","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T21:20:39Z","timestamp":1508361639000},"page":"329-333","source":"Crossref","is-referenced-by-count":9,"title":["Primary Lymphadenectomy or Primary Chemotherapy in\nAdvanced Metastatic Testicular Tumor?"],"prefix":"10.1016","volume":"9","author":[{"given":"N.","family":"Jaeger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Weissbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.E.","family":"Altwein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Kreuser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","published-online":{"date-parts":[[2017,8,11]]},"container-title":["European Urology"],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/474116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T19:08:04Z","timestamp":1570129684000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.karger.com\/Article\/FullText\/474116"}},"issued":{"date-parts":[[1983]]},"references-count":0,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,8,11]]}},"URL":"https:\/\/doi.org\/10.1159\/000474116","archive":["Portico"],"ISSN":["0302-2838","1873-7560"],"issn-type":[{"value":"0302-2838","type":"print"},{"value":"1873-7560","type":"electronic"}],"published":{"date-parts":[[1983]]}},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T11:05:55Z","timestamp":1648983955956},"reference-count":6,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.eururo.2008.07.019","type":"journal-article","created":{"date-parts":[[2008,7,16]],"date-time":"2008-07-16T00:08:08Z","timestamp":1216166888000},"page":"185-186","source":"Crossref","is-referenced-by-count":0,"title":["Editorial Comment on: Potential Impact of Postoperative Early Complications on the Timing of Adjuvant Chemotherapy in Patients Undergoing Radical Cystectomy: A High-Volume Tertiary Cancer Center Experience"],"prefix":"10.1016","volume":"55","author":[{"given":"Robert S.","family":"Svatek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2008.07.019_bib1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.eururo.2006.05.021","article-title":"Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy","volume":"51","author":"Shariat","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2008.07.019_bib2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00345-006-0113-z","article-title":"Neoadjuvant chemotherapy for bladder cancer","volume":"24","author":"Black","year":"2006","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2008.07.019_bib3","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.eururo.2007.03.086","article-title":"P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors","volume":"52","author":"Kassouf","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2008.07.019_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.eururo.2008.07.018","article-title":"Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience","volume":"55","author":"Donat","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2008.07.019_bib5","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1200\/JCO.2001.19.20.4005","article-title":"Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC","volume":"19","author":"Millikan","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2008.07.019_bib6","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.eururo.2006.07.009","article-title":"Hydronephrosis as a prognostic marker in bladder cancer in a cystectomy-only series","volume":"51","author":"Bartsch","year":"2007","journal-title":"Eur Urol"}],"container-title":["European Urology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283808008403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283808008403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T17:35:58Z","timestamp":1557682558000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283808008403"}},"issued":{"date-parts":[[2009,1]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0302283808008403"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2008.07.019","ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"published":{"date-parts":[[2009,1]]}},{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T04:24:10Z","timestamp":1649046250607},"reference-count":0,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1016\/s0302-2838(03)00491-3","type":"journal-article","created":{"date-parts":[[2003,10,16]],"date-time":"2003-10-16T12:22:25Z","timestamp":1066306945000},"page":"620-623","source":"Crossref","is-referenced-by-count":0,"title":["Congress Calendar"],"prefix":"10.1016","volume":"44","member":"78","container-title":["European Urology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283803004913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283803004913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T10:53:50Z","timestamp":1550573630000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283803004913"}},"issued":{"date-parts":[[2003,11]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["S0302283803004913"],"URL":"https:\/\/doi.org\/10.1016\/s0302-2838(03)00491-3","ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"published":{"date-parts":[[2003,11]]}},{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T07:48:56Z","timestamp":1649058536764},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.eururo.2007.09.007","type":"journal-article","created":{"date-parts":[[2007,9,19]],"date-time":"2007-09-19T15:35:18Z","timestamp":1190216118000},"page":"974-975","source":"Crossref","is-referenced-by-count":0,"title":["Editorial Comment on: Topical Prilocaine-Lidocaine Cream Combined with Peripheral Nerve Block Improves Pain Control in Prostatic Biopsy: Results from a Prospective Randomized Trial"],"prefix":"10.1016","volume":"53","author":[{"given":"Rolf","family":"von Knobloch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2007.09.007_bib1","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.eururo.2007.09.005","article-title":"Topical prilocaine-lidocaine cream combined with peripheral nerve block improves pain control in prostatic biopsy: results from a prospective randomized trial","volume":"53","author":"Raber","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2007.09.007_bib2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0022-5347(01)66464-4","article-title":"Transrectal ultrasound guided prostatic nerve blockade eases systematic needle biopsy of the prostate","volume":"155","author":"Nash","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2007.09.007_bib3","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0022-5347(05)65765-5","article-title":"Local anesthesia for ultrasound guided prostate biopsy: a prospective randomized trial comparing 2 methods","volume":"166","author":"Alavi","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2007.09.007_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0090-4295(02)01730-2","article-title":"Optimizing local anesthesia during 10-core biopsy of the prostate","volume":"60","author":"Schostak","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2007.09.007_bib5","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0302-2838(02)00072-6","article-title":"Bilateral fine-needle administered local anaesthetic nerve block for pain control during TRUS-guided multi-core prostate biopsy: a prospective randomised trial","volume":"41","author":"von Knobloch","year":"2002","journal-title":"Eur Urol"}],"container-title":["European Urology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283807011517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283807011517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T01:25:47Z","timestamp":1546565147000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283807011517"}},"issued":{"date-parts":[[2008,5]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0302283807011517"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2007.09.007","ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"published":{"date-parts":[[2008,5]]}},{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T04:23:10Z","timestamp":1648873390626},"reference-count":2,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.eururo.2006.02.021","type":"journal-article","created":{"date-parts":[[2006,2,25]],"date-time":"2006-02-25T12:16:16Z","timestamp":1140869776000},"page":"1138","source":"Crossref","is-referenced-by-count":1,"title":["Re: Emmanuel David-Montefiore, Jean-Louis Frobert, Marielle Grisard-Anaf, Jean Lienhart, Karine Bonnet, Christophe Poncelet and Emile Dara\u00ef. Peri-Operative Complications and Pain After the Suburethral Sling Procedure for Urinary Stress Incontinence: A French Prospective Randomised Multicentre Study Comparing the Retropubic and Transobturator Routes. Eur Urol 2006;49:133\u20138"],"prefix":"10.1016","volume":"49","author":[{"given":"Emile","family":"Dara\u00ef","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"David-Montefiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2006.02.021_bib1","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0090-4295(01)01340-1","article-title":"Objective and subjective cure rates after tension-free vaginal tape for treatment of urinary incontinence","volume":"58","author":"Jeffry","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2006.02.021_bib2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.pain.2005.07.004","article-title":"The measurement of postoperative pain: a comparison of intensity scales in younger and older surgical patients","volume":"117","author":"Gagliese","year":"2005","journal-title":"Pain"}],"container-title":["European Urology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283806001928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283806001928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T07:51:40Z","timestamp":1547797900000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283806001928"}},"issued":{"date-parts":[[2006,6]]},"references-count":2,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0302283806001928"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2006.02.021","ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"published":{"date-parts":[[2006,6]]}},{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T20:16:25Z","timestamp":1777925785277,"version":"3.51.4"},"reference-count":0,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1991,1,1]],"date-time":"1991-01-01T00:00:00Z","timestamp":662688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"},{"start":{"date-parts":[[1991,1,1]],"date-time":"1991-01-01T00:00:00Z","timestamp":662688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Urol"],"published-print":{"date-parts":[[1991]]},"DOI":"10.1159\/000473655","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T21:19:59Z","timestamp":1508361599000},"page":"336-338","source":"Crossref","is-referenced-by-count":8,"title":["Testicular Germ Cell Tumor Seven Years after a Retroperitoneal Germ Cell Tumor"],"prefix":"10.1016","volume":"19","author":[{"given":"A. (a)","family":"Gonz\u00e1lez Quintela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. (b)","family":"L\u03ccpez Bonet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. (a)","family":"Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. (a)","family":"Aramburo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","published-online":{"date-parts":[[2017,8,11]]},"container-title":["European Urology"],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/473655","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T19:09:58Z","timestamp":1570129798000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.karger.com\/Article\/FullText\/473655"}},"issued":{"date-parts":[[1991]]},"references-count":0,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,8,11]]}},"URL":"https:\/\/doi.org\/10.1159\/000473655","archive":["Portico"],"ISSN":["0302-2838","1873-7560"],"issn-type":[{"value":"0302-2838","type":"print"},{"value":"1873-7560","type":"electronic"}],"published":{"date-parts":[[1991]]}},{"indexed":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T01:30:34Z","timestamp":1698024634841},"reference-count":0,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1980,1,1]],"date-time":"1980-01-01T00:00:00Z","timestamp":315532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"},{"start":{"date-parts":[[1980,1,1]],"date-time":"1980-01-01T00:00:00Z","timestamp":315532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Urol"],"published-print":{"date-parts":[[1980]]},"DOI":"10.1159\/000473361","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T21:19:26Z","timestamp":1508361566000},"page":"316-317","source":"Crossref","is-referenced-by-count":5,"title":["Development of Renal Carcinoma in a Patient with Polycystic Kidneys\nUndergoing Chronic Haemodialysis"],"prefix":"10.1016","volume":"6","author":[{"given":"P.L.","family":"Oe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.H.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Donner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.J.","family":"Scholtmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","published-online":{"date-parts":[[2017,8,11]]},"container-title":["European Urology"],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/473361","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T19:07:29Z","timestamp":1570129649000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.karger.com\/Article\/FullText\/473361"}},"issued":{"date-parts":[[1980]]},"references-count":0,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,8,11]]}},"URL":"https:\/\/doi.org\/10.1159\/000473361","archive":["Portico"],"ISSN":["0302-2838","1873-7560"],"issn-type":[{"value":"0302-2838","type":"print"},{"value":"1873-7560","type":"electronic"}],"published":{"date-parts":[[1980]]}},{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T06:16:41Z","timestamp":1648793801563},"reference-count":2,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.eururo.2005.09.008","type":"journal-article","created":{"date-parts":[[2005,10,18]],"date-time":"2005-10-18T07:21:02Z","timestamp":1129620062000},"page":"1062","source":"Crossref","is-referenced-by-count":0,"title":["Reply to A. Atan, M. Murad Basar"],"prefix":"10.1016","volume":"48","author":[{"given":"Eric","family":"Wespes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2005.09.008_bib1","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0022-5347(17)43539-7","article-title":"The erectile angle: objective criterion to evaluate the papaverine test in impotence","volume":"138","author":"Wespes","year":"1987","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2005.09.008_bib2","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/S0022-5347(05)68085-8","article-title":"Treatment of intracorporeal injection non-response with sildenafil alone or in combination with triple agent intracorporeal injection therapy","volume":"162","author":"McMahon","year":"1999","journal-title":"J Urol"}],"container-title":["European Urology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283805005907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283805005907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T07:12:17Z","timestamp":1554102737000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283805005907"}},"issued":{"date-parts":[[2005,12]]},"references-count":2,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0302283805005907"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2005.09.008","ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"published":{"date-parts":[[2005,12]]}},{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:08:57Z","timestamp":1783778937822,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.eururo.2017.07.041","type":"journal-article","created":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T09:53:38Z","timestamp":1502704418000},"page":"628-634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9603-3207","authenticated-orcid":false,"given":"Michal","family":"Sarfaty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Leshno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assaf","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Neiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2017.07.041_bib0155","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/jama.292.1.97","article-title":"Renal cell carcinoma","volume":"292","author":"Curti","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2017.07.041_bib0160","unstructured":"National Cancer Institute. SEER cancer statistics factsheets: kidney and renal pelvis cancer. https:\/\/seer.cancer.gov\/statfacts\/html\/kidrp.html"},{"key":"10.1016\/j.eururo.2017.07.041_bib0165","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: kidney cancer. www.nccn.org\/professionals\/physician_gls\/pdf\/kidney.pdf"},{"key":"10.1016\/j.eururo.2017.07.041_bib0170","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(08)61039-9","article-title":"Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial","volume":"372","author":"Motzer","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2017.07.041_bib0175","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1080\/21645515.2016.1175694","article-title":"Nivolumab, anti-programmed death-1 (PD-1) monoclonal antibody immunotherapy: role in advanced cancers","volume":"12","author":"Rajan","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.eururo.2017.07.041_bib0180","unstructured":"US Food & Drug Administration. Nivolumab approval. http:\/\/wayback.archive-it.org\/7993\/20161022171021\/http:\/\/www.fda.gov\/Drugs\/InformationOnDrugs\/ApprovedDrugs\/ucm474092.htm"},{"key":"10.1016\/j.eururo.2017.07.041_bib0185","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1056\/NEJMoa1510665","article-title":"Nivolumab versus everolimus in advanced renal-cell carcinoma","volume":"373","author":"Motzer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2017.07.041_bib0190","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJMp1512750","article-title":"New math on drug cost-effectiveness","volume":"373","author":"Bach","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2017.07.041_bib0195","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1002\/cncr.30044","article-title":"Understanding the value of cancer drugs\u2014the devil is in the detail","volume":"122","author":"Goldstein","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2017.07.041_bib0200","first-page":"11","article-title":"United States life tables, 2011","volume":"64","author":"Arias","year":"2015","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.eururo.2017.07.041_bib0205","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S1470-2045(16)30125-5","article-title":"Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial","volume":"17","author":"Cella","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2017.07.041_bib0210","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.jval.2011.04.008","article-title":"Economic evaluation of everolimus versus sorafenib for the treatment of metastatic renal cell carcinoma after failure of first-line sunitinib","volume":"14","author":"Casciano","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.eururo.2017.07.041_bib0215","unstructured":"Centers for Disease Control and Prevention. Body measurements. www.cdc.gov\/nchs\/fastats\/body-measurements.htm"},{"key":"10.1016\/j.eururo.2017.07.041_bib0220","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1586\/14737167.5.2.153","article-title":"Practical approach for using Medicare data to estimate costs for cost-effectiveness analysis","volume":"5","author":"Tumeh","year":"2005","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.eururo.2017.07.041_bib0225","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jval.2011.04.004","article-title":"A trial-based assessment of the cost-utility of bevacizumab and chemotherapy versus chemotherapy alone for advanced non-small cell lung cancer","volume":"14","author":"Goulart","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.eururo.2017.07.041_bib0230","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.18553\/jmcp.2014.20.11.1086","article-title":"Do value thresholds for oncology drugs differ from nononcology drugs?","volume":"20","author":"Bae","year":"2014","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.eururo.2017.07.041_bib0235","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.2014.58.4904","article-title":"First-and second-line bevacizumab in addition to chemotherapy for metastatic colorectal cancer: a United States\u2013based cost-effectiveness analysis","volume":"33","author":"Goldstein","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2017.07.041_bib0240","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1200\/JCO.2015.61.9569","article-title":"Cost-effectiveness analysis of regorafenib for metastatic colorectal cancer","volume":"33","author":"Goldstein","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2017.07.041_bib0245","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cct.2013.12.003","article-title":"The misguided ethics of crossover trials","volume":"37","author":"Prasad","year":"2014","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.eururo.2017.07.041_bib0250","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S1470-2045(16)30107-3","article-title":"Cabozantinib versus everolimus in patients with advanced renal cell carcinoma: results of the randomized phase 3 METEOR trial","volume":"17","author":"Choueiri","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2017.07.041_bib0255","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S1470-2045(15)00290-9","article-title":"Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial","volume":"16","author":"Motzer","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2017.07.041_bib0260","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1470-2045(13)70093-7","article-title":"Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomized phase 3 trial","volume":"14","author":"Motzer","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2017.07.041_bib0265","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1200\/JCO.2013.50.3961","article-title":"Randomized phase III trial of temsirolimus versus sorafenib as second-line therapy after sunitinib in patients with metastatic renal cell carcinoma","volume":"32","author":"Hutson","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2017.07.041_bib0270","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1200\/JCO.2014.56.2736","article-title":"Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma","volume":"33","author":"Schadendorf","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2017.07.041_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-016-0571-0","article-title":"Advances in immunotherapy for melanoma","volume":"14","author":"Redman","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.eururo.2017.07.041_bib0280","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"issue":"15 Suppl","key":"10.1016\/j.eururo.2017.07.041_bib0285","doi-asserted-by":"crossref","first-page":"9506","DOI":"10.1200\/JCO.2016.34.15_suppl.9506","article-title":"Pembrolizumab plus ipilimumab for advanced melanoma: results of the KEYNOTE-029 expansion cohort","volume":"34","author":"Long","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2017.07.041_bib0290","unstructured":"Mational Institute for Health and Care Excellence. Nivolumab for previously treated advanced renal cell carcinoma, Technology appraisal guidance [TA417]. www.nice.org.uk\/guidance\/ta417"},{"key":"10.1016\/j.eururo.2017.07.041_bib0295","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1634\/theoncologist.2016-0106","article-title":"Cancer drug pricing and reimbursement: lessons for the United States from around the world","volume":"21","author":"Goldstein","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.eururo.2017.07.041_bib0300","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1470-2045(15)00449-0","article-title":"Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study","volume":"17","author":"Vogler","year":"2016","journal-title":"Lancet Oncol"}],"container-title":["European Urology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228381730670X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228381730670X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T04:37:59Z","timestamp":1659328679000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030228381730670X"}},"issued":{"date-parts":[[2018,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S030228381730670X"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2017.07.041","ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2017.07.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T20:59:58Z","timestamp":1648673998576},"reference-count":0,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1989,1,1]],"date-time":"1989-01-01T00:00:00Z","timestamp":599616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"},{"start":{"date-parts":[[1989,1,1]],"date-time":"1989-01-01T00:00:00Z","timestamp":599616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Urol"],"published-print":{"date-parts":[[1989]]},"DOI":"10.1159\/000471626","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T21:16:27Z","timestamp":1508361387000},"page":"395-397","source":"Crossref","is-referenced-by-count":3,"title":["Malignant Fibrous Histiocytoma of the Kidney"],"prefix":"10.1016","volume":"16","author":[{"given":"C.","family":"Palmes Hansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Meinert Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Holten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","published-online":{"date-parts":[[2017,8,11]]},"container-title":["European Urology"],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/471626","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T19:09:35Z","timestamp":1570129775000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.karger.com\/Article\/FullText\/471626"}},"issued":{"date-parts":[[1989]]},"references-count":0,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,8,11]]}},"URL":"https:\/\/doi.org\/10.1159\/000471626","archive":["Portico"],"ISSN":["0302-2838","1873-7560"],"issn-type":[{"value":"0302-2838","type":"print"},{"value":"1873-7560","type":"electronic"}],"published":{"date-parts":[[1989]]}},{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T17:15:27Z","timestamp":1648833327417},"reference-count":5,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.eururo.2018.10.038","type":"journal-article","created":{"date-parts":[[2018,11,10]],"date-time":"2018-11-10T14:12:47Z","timestamp":1541859167000},"page":"198","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Re: Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma"],"prefix":"10.1016","volume":"75","author":[{"given":"Steven C.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chalairat","family":"Suk-Ouichai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Lin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2018.10.038_bib0030","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.eururo.2016.11.038","article-title":"Collaborative review of risk benefit trade-offs between partial nephrectomy and radical nephrectomy in the management of anatomically complex renal masses","volume":"72","author":"Kim","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2018.10.038_bib0035","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1002\/cncr.28141","article-title":"Overall survival advantage with partial nephrectomy: a bias of observational data?","volume":"119","author":"Shuch","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2018.10.038_bib0040","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.eururo.2013.06.044","article-title":"Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904","volume":"65","author":"Scosyrev","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2018.10.038_bib0045","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2010.12.013","article-title":"A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma","volume":"59","author":"Van Poppel","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2018.10.038_bib0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/j.ackd.2017.10.010","article-title":"Assessment of kidney function in patients with cancer","volume":"25","author":"Torres de Costa e Silva","year":"2018","journal-title":"Adv Chronic Kidney Dis"}],"container-title":["European Urology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283818308303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283818308303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T14:09:44Z","timestamp":1567174184000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283818308303"}},"issued":{"date-parts":[[2019,1]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0302283818308303"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2018.10.038","ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re: Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2018.10.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T15:58:21Z","timestamp":1649001501870},"reference-count":5,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.eururo.2007.10.071","type":"journal-article","created":{"date-parts":[[2007,11,14]],"date-time":"2007-11-14T12:12:14Z","timestamp":1195042334000},"page":"105-106","source":"Crossref","is-referenced-by-count":1,"title":["Editorial Comment on: High Provider Volume is Associated with Lower Rate of Secondary Therapies after Definitive Radiotherapy for Localized Prostate Cancer"],"prefix":"10.1016","volume":"54","author":[{"suffix":"III","given":"Mack","family":"Roach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2007.10.071_bib1","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1001\/jama.296.16.1973","article-title":"Disparities in the utilization of high-volume hospitals for complex surgery","volume":"296","author":"Liu","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2007.10.071_bib2","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/jnci\/djm060","article-title":"The surgical learning curve for prostate cancer control after radical prostatectomy","volume":"99","author":"Vickers","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2007.10.071_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.eururo.2007.10.070","article-title":"High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer","volume":"54","author":"Jeldres","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2007.10.071_bib4","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1200\/JCO.2000.18.23.3904","article-title":"Preliminary results of a randomized radiotherapy dose-escalation study comparing 70Gy with 78Gy for prostate cancer","volume":"18","author":"Pollack","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2007.10.071_bib5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0360-3016(00)00479-X","article-title":"Three-dimensional conformal therapy or standard irradiation in localized carcinoma of prostate: preliminary results of a nonrandomized comparison","volume":"47","author":"Perez","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["European Urology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228380701411X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228380701411X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,4]],"date-time":"2019-05-04T11:58:36Z","timestamp":1556971116000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030228380701411X"}},"issued":{"date-parts":[[2008,7]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S030228380701411X"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2007.10.071","ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"published":{"date-parts":[[2008,7]]}},{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:44:38Z","timestamp":1740120278850,"version":"3.37.3"},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.eururo.2015.05.026","type":"journal-article","created":{"date-parts":[[2015,8,4]],"date-time":"2015-08-04T22:46:20Z","timestamp":1438728380000},"page":"536-537","source":"Crossref","is-referenced-by-count":1,"title":["Re: Comparison of MR\/Ultrasound Fusion\u2013guided Biopsy with Ultrasound-guided Biopsy for the Diagnosis of Prostate Cancer"],"prefix":"10.1016","volume":"68","author":[{"given":"Boris","family":"Gershman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Jeffrey","family":"Karnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2015.05.026_bib0030","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/jnci\/djp001","article-title":"Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context","volume":"101","author":"Draisma","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2015.05.026_bib0035","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","article-title":"Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eururo.2015.05.026_bib0040","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.eururo.2014.10.033","article-title":"Use of the Prostate Imaging Reporting and Data System (PI-RADS) for prostate cancer detection with multiparametric magnetic resonance imaging: a diagnostic meta-analysis","volume":"67","author":"Hamoen","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2015.05.026_bib0045","doi-asserted-by":"crossref","unstructured":"F\u00fctterer JJ, Briganti A, De Visschere P, et al. Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur Urol. In press. http:\/\/dx.doi.org\/10.1016\/j.eururo.2015.01.013","DOI":"10.1016\/j.eururo.2015.01.013"},{"key":"10.1016\/j.eururo.2015.05.026_bib0050","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.eururo.2014.10.050","article-title":"Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review","volume":"67","author":"Schoots","year":"2015","journal-title":"Eur Urol"}],"container-title":["European Urology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283815004285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283815004285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T08:55:38Z","timestamp":1537433738000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283815004285"}},"issued":{"date-parts":[[2015,9]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0302283815004285"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2015.05.026","ISSN":["0302-2838"],"issn-type":[{"type":"print","value":"0302-2838"}],"published":{"date-parts":[[2015,9]]}},{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:44:56Z","timestamp":1740120296324,"version":"3.37.3"},"reference-count":8,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Finnish Cancer Society"},{"DOI":"10.13039\/501100003125","name":"Finnish Cultural Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tampere University Hospital"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.eururo.2019.01.044","type":"journal-article","created":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T23:50:09Z","timestamp":1549756209000},"page":"e166-e167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reply to Jae Heon Kim and Benjamin I. Chung's Letter to the Editor re: Teemu J. Murtola, Heimo Syv\u00e4l\u00e4, Teemu Tolonen, et al. Atorvastatin Versus Placebo for Prostate Cancer Before Radical Prostatectomy\u2014A Randomized, Double-blind, Placebo-controlled Clinical Trial. Eur Urol 2018;74:697\u2013701"],"prefix":"10.1016","volume":"75","author":[{"given":"Teemu J.","family":"Murtola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heimo","family":"Syv\u00e4l\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarno","family":"Riikonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2019.01.044_bib0045","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.eururo.2018.06.037","article-title":"Atorvastatin versus placebo for prostate cancer before radical prostatectomy-a randomized, double-blind, placebo-controlled clinical trial","volume":"74","author":"Murtola","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2019.01.044_bib0050","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbrc.2016.11.021","article-title":"Additive inhibitory effects of simvastatin and enzalutamide on androgen-sensitive LNCaP and VCaP prostate cancer cells","volume":"481","author":"Syv\u00e4l\u00e4","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.eururo.2019.01.044_bib0055","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamaoncol.2015.0829","article-title":"Statin use at the time of initiation of androgen deprivation therapy and time to progression in patients with hormone-sensitive prostate cancer","volume":"1","author":"Harshman","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eururo.2019.01.044_bib0060","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.urolonc.2018.11.017","article-title":"The impact of statins in combination with androgen deprivation therapy in patients with advanced prostate cancer: a large observational study","volume":"37","author":"Anderson-Carter","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2019.01.044_bib0065","doi-asserted-by":"crossref","first-page":"19861","DOI":"10.18632\/oncotarget.24888","article-title":"Statin use and survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: the international retrospective observational STABEN study","volume":"9","author":"Gordon","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.eururo.2019.01.044_bib0070","doi-asserted-by":"crossref","first-page":"29106","DOI":"10.1038\/srep29106","article-title":"The effect of statins on prostate cancer recurrence and mortality after definitive therapy: a systematic review and meta-analysis","volume":"6","author":"Tan","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.eururo.2019.01.044_bib0075","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.euf.2016.05.004","article-title":"Statin use and prostate cancer survival in the Finnish randomized study of screening for prostate cancer","volume":"3","author":"Murtola","year":"2017","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2019.01.044_bib0080","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.eururo.2014.11.039","article-title":"Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: a meta-analysis","volume":"68","author":"Bosco","year":"2015","journal-title":"Eur Urol"}],"container-title":["European Urology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283819300909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283819300909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T16:40:52Z","timestamp":1565196052000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283819300909"}},"issued":{"date-parts":[[2019,6]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0302283819300909"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2019.01.044","ISSN":["0302-2838"],"issn-type":[{"type":"print","value":"0302-2838"}],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reply to Jae Heon Kim and Benjamin I. Chung's Letter to the Editor re: Teemu J. Murtola, Heimo Syv\u00e4l\u00e4, Teemu Tolonen, et al. Atorvastatin Versus Placebo for Prostate Cancer Before Radical Prostatectomy\u2014A Randomized, Double-blind, Placebo-controlled Clinical Trial. Eur Urol 2018;74:697\u2013701","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2019.01.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2018.06.037","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2019.01.042","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T09:18:42Z","timestamp":1697966322266},"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1983,1,1]],"date-time":"1983-01-01T00:00:00Z","timestamp":410227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"},{"start":{"date-parts":[[1983,1,1]],"date-time":"1983-01-01T00:00:00Z","timestamp":410227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Urol"],"published-print":{"date-parts":[[1983]]},"DOI":"10.1159\/000474053","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T21:21:04Z","timestamp":1508361664000},"page":"80-83","source":"Crossref","is-referenced-by-count":3,"title":["Total Cystectomy and Ureterosygmoidostomy for Carcinoma of the Bladder"],"prefix":"10.1016","volume":"9","author":[{"given":"R.","family":"Minervini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Carlino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Fiorentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","published-online":{"date-parts":[[2017,8,11]]},"container-title":["European Urology"],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/474053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T19:08:26Z","timestamp":1570129706000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.karger.com\/Article\/FullText\/474053"}},"issued":{"date-parts":[[1983]]},"references-count":0,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,8,11]]}},"URL":"https:\/\/doi.org\/10.1159\/000474053","archive":["Portico"],"ISSN":["0302-2838","1873-7560"],"issn-type":[{"value":"0302-2838","type":"print"},{"value":"1873-7560","type":"electronic"}],"published":{"date-parts":[[1983]]}},{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T18:52:20Z","timestamp":1648925540670},"reference-count":0,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1978,1,1]],"date-time":"1978-01-01T00:00:00Z","timestamp":252460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"},{"start":{"date-parts":[[1978,1,1]],"date-time":"1978-01-01T00:00:00Z","timestamp":252460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Urol"],"published-print":{"date-parts":[[1978]]},"DOI":"10.1159\/000473994","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T17:20:43Z","timestamp":1508347243000},"page":"361-365","source":"Crossref","is-referenced-by-count":0,"title":["Air Cystornetrography and Sphincter Electromyography in Patients with\nBladder Outlet Obstruction"],"prefix":"10.1016","volume":"4","author":[{"given":"Julius","family":"Esho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.O.","family":"Obasanya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","published-online":{"date-parts":[[2017,8,11]]},"container-title":["European Urology"],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/473994","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T15:06:38Z","timestamp":1570115198000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.karger.com\/Article\/FullText\/473994"}},"issued":{"date-parts":[[1978]]},"references-count":0,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,8,11]]}},"URL":"https:\/\/doi.org\/10.1159\/000473994","archive":["Portico"],"ISSN":["0302-2838","1873-7560"],"issn-type":[{"value":"0302-2838","type":"print"},{"value":"1873-7560","type":"electronic"}],"published":{"date-parts":[[1978]]}},{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T08:31:18Z","timestamp":1648715478442},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","journals.elsevierhealth.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.eururo.2016.04.008","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T12:52:01Z","timestamp":1462020721000},"page":"562-563","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["End-stage Renal Disease after Renal Surgery: Partial Nephrectomy is Protective, but to What Degree and Consequence?"],"prefix":"10.1016","volume":"70","author":[{"given":"Steven C.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe","family":"Zabell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego Aguilar","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2016.04.008_bib0055","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.eururo.2016.03.023","article-title":"End-stage renal disease after renal surgery in patients with normal preoperative kidney function: balancing surgical strategy and individual disorders at baseline","volume":"70","author":"Capitanio","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.04.008_bib0060","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.juro.2013.01.030","article-title":"The management of a clinical T1b renal tumor in the presence of a normal contralateral kidney","volume":"189","author":"Weight","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.04.008_bib0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.juro.2012.03.006","article-title":"Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis","volume":"188","author":"Kim","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.04.008_bib0070","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1002\/cncr.28141","article-title":"Overall survival advantage with partial nephrectomy: a bias of observational data?","volume":"119","author":"Shuch","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2016.04.008_bib0075","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2010.12.013","article-title":"A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma","volume":"59","author":"Van Poppel","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.04.008_bib0080","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.eururo.2013.06.044","article-title":"Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904","volume":"65","author":"Scosyrev","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.04.008_bib0085","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.juro.2015.01.093","article-title":"Decline in renal function after partial nephrectomy: etiology and prevention","volume":"193","author":"Mir","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.04.008_bib0090","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.eururo.2015.01.025","article-title":"Renal ischemia and function after partial nephrectomy: a collaborative review of the literature","volume":"68","author":"Volpe","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.04.008_bib0095","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.urology.2013.03.068","article-title":"Parenchymal volume preservation and ischemia during partial nephrectomy: functional and volumetric analysis","volume":"82","author":"Mir","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2016.04.008_bib0100","doi-asserted-by":"crossref","first-page":"e527","DOI":"10.1016\/j.juro.2015.02.1546","article-title":"Nephron-sparing surgery protects from chronic kidney disease relative to radical nephrectomy but does not impact on other-causes mortality: long-term (more than 10 years) survival and functional outcomes in patients with a T1a\u2013T1b renal mass","volume":"193","author":"Capitanio","year":"2015","journal-title":"J Urol"}],"container-title":["European Urology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283816300677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283816300677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T17:28:39Z","timestamp":1536773319000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283816300677"}},"issued":{"date-parts":[[2016,10]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0302283816300677"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2016.04.008","ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"End-stage Renal Disease after Renal Surgery: Partial Nephrectomy is Protective, but to What Degree and Consequence?","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2016.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2016.03.023","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T15:38:54Z","timestamp":1648913934229},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.eururo.2008.03.085","type":"journal-article","created":{"date-parts":[[2008,3,29]],"date-time":"2008-03-29T14:03:55Z","timestamp":1206799435000},"page":"1320","source":"Crossref","is-referenced-by-count":1,"title":["Corrigendum to: \u201cCombination of Alfuzosin and Sildenafil is Superior to Monotherapy in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction\u201d [Eur Urol 2007;51:1717\u201323]"],"prefix":"10.1016","volume":"53","author":[{"given":"Steven A.","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo R.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis E.","family":"Te","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["European Urology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283808004053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283808004053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T01:48:19Z","timestamp":1548553699000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283808004053"}},"issued":{"date-parts":[[2008,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0302283808004053"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2008.03.085","ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"published":{"date-parts":[[2008,6]]}},{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T07:47:02Z","timestamp":1774943222681,"version":"3.50.1"},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/s0302-2838(26)00935-8","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:44:04Z","timestamp":1770975844000},"page":"S1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["P0016 Distinct urinary microbial profiles in calcium oxalate urolithiasis: A 16S rRNA-based comparative study"],"prefix":"10.1016","volume":"89","author":[{"given":"W.K.","family":"Hwang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.B.","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.S.","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.W.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.M.","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.T.","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.G.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["European Urology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283826009358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283826009358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T06:13:16Z","timestamp":1774937596000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283826009358"}},"issued":{"date-parts":[[2026,3]]},"references-count":0,"alternative-id":["S0302283826009358"],"URL":"https:\/\/doi.org\/10.1016\/s0302-2838(26)00935-8","ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P0016 Distinct urinary microbial profiles in calcium oxalate urolithiasis: A 16S rRNA-based comparative study","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0302-2838(26)00935-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T07:46:37Z","timestamp":1774943197052,"version":"3.50.1"},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/s0302-2838(26)00930-9","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:44:10Z","timestamp":1770975850000},"page":"S1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["P0009 Mendelian disorders are an uncommon cause of kidney stone disease"],"prefix":"10.1016","volume":"89","author":[{"given":"C.","family":"Lovegrove","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Bull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.V.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Furniss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Howles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["European Urology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283826009309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283826009309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T06:13:13Z","timestamp":1774937593000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283826009309"}},"issued":{"date-parts":[[2026,3]]},"references-count":0,"alternative-id":["S0302283826009309"],"URL":"https:\/\/doi.org\/10.1016\/s0302-2838(26)00930-9","ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P0009 Mendelian disorders are an uncommon cause of kidney stone disease","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0302-2838(26)00930-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}],"items-per-page":20,"query":{"start-index":0,"search-terms":null}}}